These include α-synuclein for Parkinson’s disease and related synucleinopathies, TDP-43 for amyotrophic lateral sclerosis and frontotemporal dementia, as well as mutant huntingtin in Huntington’s disease and poly-Q aggregates in spinocerebellar ataxias. This evidence concerns the gene SNCA and juvenile Huntington disease.